185 related articles for article (PubMed ID: 3092888)
41. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
Kelsey PR; Stevenson KJ; Poller L
Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
[TBL] [Abstract][Full Text] [Related]
42. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
Favaloro EJ; Mohammed S; Curnow J; Pasalic L
Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
[TBL] [Abstract][Full Text] [Related]
43. Lupus anticoagulants in children.
Singh AK; Rao KP; Kizer J; Lazarchick J
Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
[TBL] [Abstract][Full Text] [Related]
44. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
[TBL] [Abstract][Full Text] [Related]
45. [Eclampsia, systemic lupus erythematosus and lupus anticoagulant].
Alijotas Reig J; Puig de Morales E
Rev Clin Esp; 1990 May; 186(8):411-2. PubMed ID: 2122502
[No Abstract] [Full Text] [Related]
46. Lupus anticoagulant and transient severe bleeding tendency in a girl aged nine years.
Nanulescu M; Trif I; Cucuianu M; Rus HG; Cristea A; Niculescu F
Med Interne; 1988; 26(2):115-9. PubMed ID: 3133747
[TBL] [Abstract][Full Text] [Related]
47. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
48. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
[TBL] [Abstract][Full Text] [Related]
49. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.
Asherson RA; Mackay IR; Harris EN
Br Heart J; 1986 Aug; 56(2):190-3. PubMed ID: 3089242
[TBL] [Abstract][Full Text] [Related]
50. The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant.
Liu HW; Wong KL; Lin CK; Wong WS; Tse PW; Chan GT
Br J Haematol; 1989 Jun; 72(2):229-34. PubMed ID: 2503025
[TBL] [Abstract][Full Text] [Related]
51. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.
Rosove MH; Ismail M; Koziol BJ; Runge A; Kasper CK
Blood; 1986 Aug; 68(2):472-8. PubMed ID: 3730611
[TBL] [Abstract][Full Text] [Related]
52. Lupus anticoagulants.
Shapiro SS; Thiagarajan P
Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
[No Abstract] [Full Text] [Related]
53. A quantitative, semi-automated and computer-assisted test for lupus anticoagulant.
Schjetlein R; Sletnes KE; Wisløff F
Thromb Res; 1993 Jan; 69(2):239-50. PubMed ID: 8446953
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of recently described tests for detection of the lupus anticoagulant.
Forastiero RR; Cerrato GS; Carreras LO
Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
[TBL] [Abstract][Full Text] [Related]
55. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
[TBL] [Abstract][Full Text] [Related]
56. [Circulating anticoagulants and pregnancy: a risky combination].
Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
[TBL] [Abstract][Full Text] [Related]
57. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
[TBL] [Abstract][Full Text] [Related]
58. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.
Cohen AJ; Philips TM; Kessler CM
Ann Intern Med; 1986 Feb; 104(2):175-80. PubMed ID: 3080933
[TBL] [Abstract][Full Text] [Related]
59. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
Thom J; Ivey L; Gilmore G; Eikelboom JW
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
